Feature | August 28, 2014

University of Michigan First in Nation to Implant Device for Tricuspid Valve Replacement

Heart team implants Edwards Sapien valve for landmark transcatheter tricuspid valve replacement


August 28, 2014 — The University of Michigan Frankel Cardiovascular Center is the first heart center in the nation to perform percutaneous implantation of the Edwards Sapien valve to replace a patient’s tricuspid valve. Cardiac surgeon Steven Bolling, M.D., interventional cardiologist Stanley Chetcuti, M.D., interventional cardiologist Daniel Menees, M.D., and cardiac surgeon Matthew Romano, M.D., successfully completed the procedure Aug. 11.

Because of the less invasive approach, the 47-year-old patient was discharged after only a two-day hospital stay. “Minimally invasive surgery for tricuspid valve replacement is a new solution for the dilemma of treating valve disease in which repeat surgeries are often needed but problematic,” said Bolling, director of the U-M Mitral Valve Clinic. “This was a rewarding result for all of us.”

Compared to the rapid expansion of transcatheter aortic valve replacement (TAVR) procedures, transcatheter tricuspid valve-in-valve implantation is just beginning.

The U-M cardiac team replaced the patient’s diseased heart valve to improve blood flow on the right side of the heart. Tricuspid valve stenosis had caused the valve to narrow. Adding to the complexity, her heart valve had been replaced before using animal tissue.

For more information: www.umcvc.org


Additional Content

News | Heart Valve Technology

Oct. 29, 2026 — Abbott has initiated the CROWN-MV pivotal trial evaluating the safety and effectiveness of its ...

Home November 05, 2026
Home
News | Heart Valve Technology

Oct. 21, 2026 — Edwards Lifesciences Corp. recently announced that the U.S. Food and Drug Administration (FDA) has ...

Home October 23, 2026
Home
News | Heart Valve Technology

Sept. 22, 2026 — Following transcatheter aortic valve implantation (TAVI), disturbances in the heart’s electrical ...

Home September 25, 2026
Home
News | Heart Valve Technology

Sept. 22, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai have received a $3.6 million, four-year ...

Home September 24, 2026
Home
News | Heart Valve Technology

June 29, 2026 — Laplace Interventional recently announced that the U.S. Food and Drug Administration (FDA) has approved ...

Home July 02, 2026
Home
Subscribe Now